Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Decrease in the blood toxicity of antitumor preparations during enterosorption].

L V Bonatskaia, V M Plotnikov, V G Nikolaev

    Eksperimental'Naia Onkologiia
    |January 1, 1989
    PubMed
    Summary

    Activated charcoal SCN given orally to rats did not interfere with the effectiveness of chemotherapy drugs like cyclophosphamide. It also protected bone marrow blood cell production during cancer treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Efficacy of dispersed fibrous carbon sorbent in treatment of malignant fungating wounds.

    Experimental oncology·2021
    Same author

    Comparative study of biochemical and morphological parameters in rats with Walker 256 and Walker 256/DOX carcinosarcoma.

    Experimental oncology·2021
    Same author

    Indicators of chemiluminescent and bioluminescent tests of biological liquids in the assessment of physical health.

    Klinicheskaia laboratornaia diagnostika·2020
    Same author

    Structural changes of serum albumin in response to oxidative stress caused by Walker-256 carcinosarcoma growth.

    Experimental oncology·2020
    Same author

    Adsorptive therapy as a modificator for tumor-host interaction.

    Experimental oncology·2019
    Same author

    Enterosorption combined with granulocyte colony stimulating factor decreases melphalan gonadal toxicity.

    Experimental oncology·2016

    Area of Science:

    • Oncology
    • Pharmacology
    • Hematology

    Context:

    • Chemotherapy is a cornerstone of cancer treatment, but often causes significant side effects.
    • Activated charcoal is known for its adsorbent properties.
    • Investigating adjunct therapies to mitigate chemotherapy side effects is crucial.

    Purpose:

    • To evaluate the effect of activated charcoal SCN on the efficacy of common anticancer drugs.
    • To assess the protective potential of activated charcoal SCN on bone marrow hematopoiesis during chemotherapy.

    Summary:

    • Peroral administration of activated charcoal SCN in rats bearing Guerin carcinoma and Svec erythroleucosis was studied.
    • The results indicate that activated charcoal SCN does not impede the antitumoral effects of cyclophosphamide, methotrexate, and carminomycin.
    • Furthermore, it demonstrated a protective effect on medullar hematopoiesis.

    Impact:

    • This study suggests that activated charcoal SCN can be a beneficial adjunct therapy in cancer treatment.
    • It may help preserve bone marrow function, potentially improving patient tolerance to chemotherapy.
    • Further research could explore its role in human clinical trials for cancer patients.

    Related Experiment Videos